Richard Malamut is EVP and Chief Medical Officer of COLLEGIUM PHARMACEUTICAL, INC. Currently has a direct ownership of 130,264 shares of COLL, which is worth approximately $4.19 Million. The most recent transaction as insider was on Feb 10, 2022, when has been sold 6,300 shares (Common Stock) at a price of $17.63 per share, resulting in proceeds of $111,069. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 130K
0% 3M change
0% 12M change
Total Value Held $4.19 Million

Richard Malamut Transaction History

Date Transaction Value Shares Traded Shares Held Form
Feb 10 2022
SELL
Payment of exercise price or tax liability
$111,069 $17.63 p/Share
6,300 Reduced 4.61%
130,264 Common Stock
Feb 10 2022
BUY
Grant, award, or other acquisition
-
43,006 Added 23.95%
136,564 Common Stock
Apr 01 2021
SELL
Payment of exercise price or tax liability
$72,922 $23.38 p/Share
3,119 Reduced 3.23%
93,558 Common Stock
Feb 10 2021
SELL
Payment of exercise price or tax liability
$59,685 $25.95 p/Share
2,300 Reduced 2.32%
96,677 Common Stock
Jan 19 2021
BUY
Grant, award, or other acquisition
-
39,147 Added 28.34%
98,977 Common Stock

Also insider at

CHRO
Chromocell Therapeutics Corp
RM

Richard Malamut

EVP and Chief Medical Officer
Stoughton, MA

Track Institutional and Insider Activities on COLL

Follow COLLEGIUM PHARMACEUTICAL, INC and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells COLL shares.

Notify only if

Insider Trading

Get notified when an Collegium Pharmaceutical, Inc insider buys or sells COLL shares.

Notify only if

News

Receive news related to COLLEGIUM PHARMACEUTICAL, INC

Track Activities on COLL